These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 20233112)

  • 21. Relationship between global cognitive decline and depressive symptoms in multiple sclerosis.
    Barwick FH; Arnett PA
    Clin Neuropsychol; 2011 Feb; 25(2):193-209. PubMed ID: 21246447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cognitive functions in multiple sclerosis. Bibliographic review (1980-1991)].
    Vicens A; de Castro P
    Neurologia; 1992; 7(7):185-9. PubMed ID: 1419088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive changes in early MS: a call for a common framework.
    Achiron A; Barak Y
    J Neurol Sci; 2006 Jun; 245(1-2):47-51. PubMed ID: 16635495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventricular size, cognitive function and depression in patients with multiple sclerosis.
    Clark CM; James G; Li D; Oger J; Paty D; Klonoff H
    Can J Neurol Sci; 1992 Aug; 19(3):352-6. PubMed ID: 1393845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment in different MS subtypes and clinically isolated syndromes.
    Potagas C; Giogkaraki E; Koutsis G; Mandellos D; Tsirempolou E; Sfagos C; Vassilopoulos D
    J Neurol Sci; 2008 Apr; 267(1-2):100-6. PubMed ID: 17997417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal neuropsychological assessment in pediatric multiple sclerosis.
    MacAllister WS; Christodoulou C; Milazzo M; Krupp LB
    Dev Neuropsychol; 2007; 32(2):625-44. PubMed ID: 17931122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropsychiatric disorders in multiple sclerosis].
    García-Moreno JM; Duque P; Izquierdo G
    Rev Neurol; 2001 Sep 16-30; 33(6):560-7. PubMed ID: 11727241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis.
    Haase CG; Tinnefeld M; Faustmann PM
    Neuroimmunomodulation; 2004; 11(6):365-72. PubMed ID: 15467351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.
    Amato MP; Zipoli V; Portaccio E
    J Neurol Sci; 2006 Jun; 245(1-2):41-6. PubMed ID: 16643953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive changes in multiple sclerosis.
    Amato MP; Zipoli V; Portaccio E
    Expert Rev Neurother; 2008 Oct; 8(10):1585-96. PubMed ID: 18928350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personality characteristics and disorders in multiple sclerosis patients: assessment and treatment.
    Stathopoulou A; Christopoulos P; Soubasi E; Gourzis P
    Int Rev Psychiatry; 2010; 22(1):43-54. PubMed ID: 20233113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.